-       Report 
- July 2025
-  200 Pages 
- Japan 
   From       €2227EUR$2,490USD£1,959GBP 
          -       Report 
- March 2022
-  300 Pages 
- Global 
   From       €4472EUR$5,000USD£3,934GBP 
          -       Report 
- January 2023
-  50 Pages 
- China 
   From       €2683EUR$3,000USD£2,360GBP 
          -       Report 
- April 2021
-  50 Pages 
- China 
   From       €2326EUR$2,600USD£2,046GBP 
          -       Report 
- July 2018
-  30 Pages 
- China 
   From       €1968EUR$2,200USD£1,731GBP 
             -       Report 
- August 2024
-  150 Pages 
- Global 
   From       €2683EUR$3,000USD£2,360GBP 
      €3354EUR$3,750USD£2,950GBP 
            -       Report 
- October 2024
-  237 Pages 
- Global 
   From       €5689EUR$6,360USD£5,004GBP 
      €7111EUR$7,950USD£6,255GBP 
            -       Report 
- April 2023
-  224 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
      €6708EUR$7,500USD£5,901GBP 
            -       Report 
- February 2023
-  220 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
      €6708EUR$7,500USD£5,901GBP 
          -       Report 
- April 2023
-  120 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- April 2024
-  137 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- September 2023
-  83 Pages 
- Israel 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- October 2024
-  149 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- July 2024
-  161 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- September 2023
-  128 Pages 
- North America 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- September 2023
-  143 Pages 
- Middle East, Africa 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- September 2023
-  143 Pages 
- Asia Pacific 
   From       €1342EUR$1,500USD£1,180GBP 
            -       Report 
- March 2024
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- October 2022
-  216 Pages 
- Middle East 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- April 2023
-  147 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
       
      Antithrombotics are drugs used to prevent the formation of blood clots, which can lead to cardiovascular diseases such as stroke and heart attack. These drugs work by inhibiting the activity of clotting factors in the blood, thus preventing the formation of clots. Common antithrombotics include aspirin, clopidogrel, warfarin, and heparin. Aspirin is the most widely used antithrombotic, and is often prescribed to reduce the risk of stroke and heart attack. Clopidogrel is used to prevent blood clots    in patients with coronary artery disease, while warfarin is used to prevent and treat blood clots in patients with atrial fibrillation. Heparin is used to prevent and treat deep vein thrombosis and pulmonary embolism.
The antithrombotics market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in the market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. These companies are continuously developing new products to meet the needs of patients and healthcare providers. Show Less   Read more